Literature DB >> 5771574

Asparaginase.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5771574      PMCID： PMC1983389     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  9 in total

1.  TUMOR INHIBITORY EFFECT OF L-ASPARAGINASE FROM ESCHERICHIA COLI.

Authors:  L T MASHBURN; J C WRISTON
Journal:  Arch Biochem Biophys       Date:  1964-05       Impact factor: 4.013

2.  [Inhibition of malignant human neoplasms with L-asparaginase].

Authors:  H F Oettgen; H K Schulten
Journal:  Klin Wochenschr       Date:  1969-01-15

3.  [On the enzyme therapy of leukemias].

Authors:  C G Schmidt; W M Gallmeier
Journal:  Dtsch Med Wochenschr       Date:  1968-11-29       Impact factor: 0.628

Review 4.  [L-asparaginase--first specific cytostatic].

Authors:  H Marquardt
Journal:  Arzneimittelforschung       Date:  1968-11

5.  Toxic and antineoplastic effects of L-asparaginase. Study of mice with lymphoma and normal monkeys and report on a child with leukemia.

Authors:  W C Dolowy; D Henson; J Cornet; H Sellin
Journal:  Cancer       Date:  1966-12       Impact factor: 6.860

Review 6.  Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review.

Authors:  R H Adamson; S Fabro
Journal:  Cancer Chemother Rep       Date:  1968-10

7.  L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia.

Authors:  J M Hill; J Roberts; E Loeb; A Khan; A MacLellan; R W Hill
Journal:  JAMA       Date:  1967-11-27       Impact factor: 56.272

8.  [On blood coagulation disorders during enzyme therapy of malignant tumors and hemoblastoses].

Authors:  H W Stier; W M Gallmeier; C G Schmidt
Journal:  Dtsch Med Wochenschr       Date:  1969-02-07       Impact factor: 0.628

9.  Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum.

Authors:  J G KIDD
Journal:  J Exp Med       Date:  1953-12       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.